Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
flu-like illness
interferon beta 1-b
interleukin 1
interleukin 6
meningitis
meningitis, aseptic
meningitis, children
meningitis, CSF findings in
multiple sclerosis
multiple sclerosis, treatment of
steroid
steroid therapy, CNS treatment and complications with
tumor necrosis factor
Showing articles 250 to 300 of 1188 << Previous Next >>

Glatiramer Acetate--Associated, CD30+, Primary, Cutaneous, Anaplastic Large-Cell Lymphoma
Arch Neurol 65:1378-1379, Madray,M.M.,et al, 2008

Combining Beta Interferon and Atorvastatin May Increase Disease Activity in Multiple Sclerosis
Neurol 71:1390-1395,1386, Birnbaum,G.,et al, 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Controlled Trial of High-Concentration Capsaicin Patch for Treatment of Painful HIV Neuropathy
Neurol 70:2305-2313, Simpson,D.M.,et al, 2008

Spinal Muscular Atrophy
Lancet 371:2120-2133, Lunn,M.R. &Wang,C.H., 2008

Neurofibromatosis
JAMA 300:352, Torpy,J.M.,et al., 2008

Effect of Simvastatin on Cognitive Functioning in Children With Neurofibromatosis Type 1: A Randomized Controlled Trial
JAMA 300:287-294, Krab,L.C.,et al., 2008

JC Viral Infection-Related Cerebellar Degeneration as the First Manifestation of AIDS
Eur Neurol 59:205-207, Shin,H.-W.,et al, 2008

Diffusion-Weighted Imaging in Brain Aspergillesis
Eur J Neurol 14:912-916, Charlot,M.,et al, 2007

Corticosteroids for Acute Bacterial Meningitis
NEJM 357:2507-2509, Greenwood,B.M., 2007

HIV Infection Presenting with Motor Axonal Variant of Guillain-Barre Syndrome
J Clin Neuromusc Dis 9:303-305, Wagner, J.C. and Bromberg, M.B., 2007

Optic Pathway Gliomas in Neurofibromatosis-1: Controversies and Recommendations
Ann Neurol 61:189-198, Listernick,R.,et al, 2007

Randomized, Double-Blind, Dose-Comparison Study of Glatiramer Acetate in Relapsing-Remitting MS
Neurol 68:939-944, Cohen,J.A.,et a, 2007

Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report
Neurol 68:977-984, Goodin,D.S.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

Inclusion Body Mositis With Human Immunodeficiency Virus Infection: Four Cases with Clonal Expansion of Viral-Specific T Cells
Ann Neurol 61:466-475, Dalakas,M.,et al, 2007

Multiple Ring Enhancing Lesions in Brain MRI of a Patient with AIDS
JNNP 78:526, Tahir,M.,et al, 2007

Neurological Findings in Aminoacylase 1 Deficiency
Neurol 68:2151-2153, Sass,J.O.,et al, 2007

Inflammatory Progressive Multifocal Leukoencephalopathy in Human Immunodeficiency Virus-Negative Patients
Ann Neurol 62:34-39, Huang,D.R.,et al, 2007

Effect of Early Verus Delayed Interferon Beta-1b Treatment on Disability After a First Clinical Event Suggestive of Multiple Sclerosis: A 3-Year Follow-Up Analysis of the BENEFIT Study
Lancet 370:389-397, Kappos,L.,et al, 2007

Mangnetic Resonance Imaging Effects of Interferon Beta-1b in the BENEFIT Study: Integrated 2-Year Results
Arch Neurol 64:1292-1298, Barkhof,F.,et al, 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 69:1552-1553, Sorenson,P.S. &Bertolotto,A., 2007

How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS?
Neurol 69:1498-1507, Brown,M.G.,et al, 2007

Stroke in Patients with Human Immunodeficiency Virus Infection
JNNP 78:1320-1324,1291, Tipping,B.,et al, 2007

Charcot Neuroarthropathy in the Era of HAART
Lancet 367:274, Oh-Park,M.,et al, 2006

Safety and Tolerability of Interferon Beta-1b in Pediatric Multiple Sclerosis
Neurol 66:472-476, Banwell,B.,et al, 2006

Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006

IM Interferon B-1a Delays Definite Multiple Sclerosis 5 Years After a First Demyelinating Event
Neurol 66:678-684, CHAMPIONS Study Group, 2006

Valproic Acid Adjunctive Therapy for HIV-Associated Cognitive Impairment: A First Report
Neurol 66:919-921, Schifitto,G.,et al, 2006

Cerebral Vasculopathy with aneurysm Formation in HIV-infected Young Adults
Neurol 66:1121-1122, Kossorotoff,M.,et al, 2006

Interferon beta-1a Treatment in Childhood and Juvenile-Onset Multiple Sclerosis
Neurol 67:511-513, Tenembaum,S.N. &Segura,M.J., 2006

Immune Reconstitution Inflammatory Syndrome in the CNS of HIV Infected Patients
Neurol 67:383-388, Venkataramana,A.,et al, 2006

Characteristics and Antecedents of Progressive Multifocal Leukoencephalopathy in an Insured Population
Neurol 67:884-886, Eng,P.M.,et al, 2006

Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings
MMWR 55:1-17, Gerberding, J.L.,et al, 2006

Immune Reconstitution Inflammatory Syndrome Associated with PML in AIDS: A Treatable Disorder
Neurol 67:1692-1694, Martinez,J.V.,et al, 2006

Treatment With Interferon beta-1b Delays Conversion to Clinically Definite and McDonald MS in Patients With Clinically Isolated Syndromes
Neurol 67:1242-1249, Kappos,L.,et al, 2006

Clinicopath Conf, Neurofibromatosis Type 1, with Multiple Spinal Neurofibromas
NEJM 352:1800-1808, Case 13-2005, 2005

Anti-Sulfatide Antibodies in HIV-Infected Individuals with Sensory Neuropathy
Neurol 64:1632-1634, Lopate,G.,et al, 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

Enhanced Benefit of Increasing Interferon Beta-1a Dose and Frequency in Relapsing Multiple Sclerosis
Arch Neurol 62:785-792, Schwid,S.R.,et al, 2005

Brachial Amyotrophic Diplegia in a Patient with Human Immunodeficiency Virus Infection
Arch Neurol 62:817-823, Berger,J.R.,et al, 2005

JC Virus Granule Cell Neuronopathy: A Novel Clinical Syndrome Distinct from Progressive Multifocal Leukoencephalopathy
Ann Neurol 57:576-580, Koralnik,I.J.,et al, 2005

Neutralizing Anti-IFN-B Antibodies
Neurol 65:6-8, Giovannoni,G.&Goodman,A., 2005

Life-Threatening Acute Pancreatitis Associated with Interferon Beta-1a Treatment in Multiple Sclerosis
Neurol 65:170-171, Midgard,R.,et al, 2005

Ventriculitis and Hydrocephalus:An Unusual Presentation of Toxoplasmosis in an Adult with Human Immunodeficiency Virus
JNNP 76:1074, deSilva,T.,et al, 2005

CT and MRI Findings of Intracranial Lymphoma
AJR 184:1679-1685, Slone,H.W.,et al, 2005

Polyneuropathy Associated with Interferon Beta Treatment in Patients with Multiple Sclerosis
Neurol 65:456-458, Ekstein,D.,et al, 2005

Clinical Features of Status Epilepticus in Patients with HIV Infection
Neurol 65:314-316, Lee,K.C.,et al, 2005

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005



Showing articles 250 to 300 of 1188 << Previous Next >>